|
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma orOcular Hypertension.
|
Ongoing
|
Bimatoprost SR
|
3
|
192024-092
|
King Khaled Eye Specialist Hospital (Riyadh), King Abdullah Medical City (Makkah)
|
|
Tracking Biologics Along the Silk Road
|
Ongoing
|
Infliximab / Golimumab / Ustekinumab
|
4
|
C0168ARA40
|
King Khalid University Hospital (Riyadh)
|
|
Efficacy and Safety Assessment of NIlotinib in Chronic Myeloid Leukemia (CML) Patients with Suboptimal Response on Imatinib Therapy (NISRI)
|
Ongoing
|
NILOTINIB
|
4
|
RC12/052/R
|
King Abdulaziz Medical City NG (Riyadh), King Fahad Specialist Hospital (Dammam)
|
|
Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers, An International, Multicenter, Double Blind, Randomized Placebo Controlled Phase 3 trial (ICR-02/ASCOLT)
|
Ongoing
|
Aspirin
|
3
|
ICR-02/ASCOLT
|
King Fahad Medical City (Riyadh)
|
|
A study of the factors predicting radiation exposure to contacts of Saudi patients treated with radioactive iodine (I 131): A preliminary study for patients’ criteria selection for possible high dose I131 therapy on out-patient basis in the future
|
Completed
|
131 Iodine
|
4
|
(version#1) dated 10-Apr-14
|
King Abdullah Medical City (Makkah)
|
|
Middle East Observational Study in Metastatic Soft Tissue Sarcoma: An epidemiological study on the treatment patterns
|
Ongoing
|
N/A
|
4
|
VEG201319
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
Prospective, multicentre, international Registry of male and female patients newly diagnosed with Atrial Fibrillation and treated with Rivaroxaban
|
Ongoing
|
Rivaroxaban
|
4
|
TRI08890
|
Armed Forces Hospital (Southern Region)
|
|
(FLASH study)A 12-week treatment, multi-center, randomized, doubleblind,double-dummy, parallel group study to assess the efficacy and safety of switching fromsalmeterol/fluticasone to QVA149 (indacaterolmaleate/glycopyrronium bromide) in symptomatic COPD patients
|
Ongoing
|
Ultibro breezhaler
|
4
|
A3405 V01
|
King Fahad Medical City (Riyadh), King Fahad University Hospital (Al-Khobar), King Abdulaziz Medical City NG (Jeddah)
|
|
XALIA LEA- Xarelto® for Long-term and Initial Anticoagulation in VenousThromboembolism (VTE) in Latin America,EMEA and Asia
|
Ongoing
|
Rivaroxaban
|
4
|
17237
|
King Fahad Medical City (Riyadh), King Fahad Hospital (Madinah), King Faisal Hospital (Taif), Hira Hospital (Makkah)
|
|
Prospective Multicentre Observational Registry Of Treatments And Outcomes In Patients With Chronic
|
Ongoing
|
N/A
|
4
|
ONC-MA1002
|
Aseer Central Hospital
|
